RxDoctor Payments Data

Georgina Srinivas Rao, MD

Psychiatry · St Charles, ILNPI 1306971015

Payments from drug & device makers

$493in general payments, 2019–2025

Across 22 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$258
  • Corium, LLC$54
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52
  • AbbVie$43
  • Supernus Pharmaceuticals, Inc.$25
  • Otsuka America Pharmaceutical, Inc.$25
  • plus $36 from 2 others

What the payments were for

  • Food & beverage$493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$493 in reported general payments places this provider in the 65th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$70,117
Medicare patients
91
Services billed
638

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl27$26,299
FetzimaLevomilnacipran Hcl26$12,215
Vilazodone Hcl23$3,405
Aripiprazole36$2,927
Duloxetine Hcl78$2,368
Venlafaxine Hcl ErVenlafaxine Hcl63$1,601
Quetiapine Fumarate67$1,309
Escitalopram Oxalate64$1,054
Bupropion Hcl SrBupropion Hcl54$956
Mirtazapine36$911
Trazodone Hcl73$898
Clonazepam114$761
Gabapentin52$759
Olanzapine26$679
Sertraline Hcl45$669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$258$26,29927 claims
AbbVieFetzima$43$12,21526 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in St Charles

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →